Human pulp stem cells (PSCs) include dental pulp stem cells (DPSCs) isolated from dental pulp tissues of human extracted permanent teeth and stem cells from human exfoliated deciduous teeth (SHED). Depending on their multipotency and sensitivity to local paracrine activity, DPSCs and SHED exert therapeutic applications at multiple levels beyond the scope of the stomatognathic system. This review is specifically concentrated on PSC-updated biological characteristics and their promising therapeutic applications in (pre)clinical practice. Biologically, distinguished from conventional mesenchymal stem cell markers in vitro, NG2, Gli1, and Celsr1 have been evidenced as PSC markers in vivo. Both perivascular cells and glial cells account for PSC origin. Therapeutically, endodontic regeneration is where PSCs hold the most promises, attributable of PSCs' robust angiogenic, neurogenic, and odontogenic capabilities. More recently, the interplay between cell homing and liberated growth factors from dentin matrix has endowed a novel approach for pulp-dentin complex regeneration. In addition, PSC transplantation for extraoral tissue repair and regeneration has achieved immense progress, following their multipotential differentiation and paracrine mechanism. Accordingly, PSC banking is undergoing extensively with the intent of advancing tissue engineering, disease remodeling, and (pre)clinical treatments.
periapical cyst contains cells with MSCs-like properties, have laid the groundwork for identifying a rich source of stem cells without any interference with the surrounding healthy tissue. Among these stem cells, DPSCs and SHED are noteworthy for their easy accessibility from teeth, which are regarded as disposable during occlusion management. DPSCs are derived from impacted third molars and orthodontic teeth, as well as supernumerary teeth. Compared with DPSCs isolated from permanent teeth, SHED obtained from exfoliated primary teeth show advantage on their painless collection procedures with minimal invasion. Pulp stem cells (PSCs) from human permanent and deciduous teeth, DPSCs and SHED, are herein focused on to emphasize their biological characteristics such as cell markers, multipotency and origin, and potential therapeutic applications, including endodontic regeneration, extraoral tissue repair and regeneration, as well as rising cell banking, in an attempt to shed light on potential translation in clinical settings.
| Biological characteristics
Both credited to MSCs, DPSCs and SHED possess similar features to BMSCs. For example, both cell types are plastic-adherent and can form colonies. However, biological variations related to anatomical localizations might exist. More specifically, PSCs from different dental pulp sources (permanent teeth or deciduous teeth) might exhibit different biological characteristics, which might consequently determine preferable clinical applications. Hence, a better understanding of biological characteristics of PSCs can inform enormous achievements for their potentials in regenerative medicine and novel developments for tissue engineering. Herein, cell markers, multipotency, and origin will be illustrated correspondingly.
| Cell markers
Identification of stem cell markers is a prerequisite to select appropriate cell population to achieve the therapeutic efficacy. Considering that cells from the same organ or tissue will have the same commonalities, both DPSCs and SHED share a phenotypic profile of MSCs and express multiple conventional MSC markers, including but not limited to CD13, CD29, CD44, CD73, CD90, CD105, CD106, CD146, CD166, CD271, Stro-1, and Stro-3, while negative for CD3, CD8, CD11b (or CD14), CD15, CD19 (or CD79α), CD33, CD34, CD45, CD71, CD117, and HLA-DR. [6] [7] [8] [9] [10] [11] Specifically, under basal conditions without any stimulation toward differentiation, osteogenic markers, such as osteonectin, osteocalcin, osteopontin, bone morphogenetic protein 2 (BMP-2), BMP-4, runt-related transcription factor 2 (Runx2) and type I collagen, chondrogenic markers, such as type II collagen, SRY (Sex-Determining Region Y)-Box 9 (Sox9), adipogenic markers, such as leptin, adipophilin and peroxisome proliferator-activated receptor gamma and myogenic markers, such as desmin, myogenin, myosin IIa, and alpha-smooth muscle actin (αSMA) are demonstrated, respectively. 8 Intriguingly, transcription factors, such as octamerbinding transcription factor 4 (OCT4), reduced expression protein 1, Sox2, NANOG, forkhead box D3, and lin-28 homolog A, which are responsible for the maintenance of pluripotency in early embryos and embryonic stem cells are verified as well, 8, 9, 12 indicative of promising primitiveness and multipotency of PSCs for regenerative medicine. In F I G U R E 1 Available human dental mesenchymal stem cells. Adapted from Reference 1 with permission. Human dental mesenchymal stem cells can be harvested from healthy toothrelated pulp tissue (DPSCs and SHED), dental follicle (DFPCs), periodontal ligament (PDLSCs) and apical papilla (SCAP), as well as gingiva (GMSCs) and alveolar bone marrow (BMSCs). Specifically, DPSCs and SHED have attracted extensive attention considering they are easily obtained from extracted permanent teeth and exfoliated deciduous teeth, which are previously considered as medical garbage
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Pulp stem cells can be readily harvested from dental pulp tissue of extracted permanent teeth and exfoliated deciduous teeth, respectively. However, a systematic and comprehensive review about pulp stem cells in terms of biological attributes and therapeutic applications is lacking. Accordingly, this review is concentrated on pulp stem cells to emphasize their updated biological characteristics such as cell markers, multipotency and origin, and promising therapeutic applications, including endodontic regeneration and extraoral tissue repair and regeneration, as well as rising cell bank with the intent of enhancing the understanding of dental mesenchymal stem cells and advancing associated tissue engineering and disease treatment.
terms of neural crest derivation, neurogenic markers, such as c-fos, γ-enolase, nestin, βIII tubulin, A2B5, musashi-1, neurofilament heavy and neurofilament light, microtubule-associated protein 2, glial fibrillary acidic protein, and oligo dendrocyte-associated CNPase are also identified on PSCs. 8, 13 Given that DPSCs and SHED are derived from dental pulp tissues of different age groups, discriminated gene expressions, such as higher embryonic markers in SHED and higher neurogenic markers in DPSCs, have been observed, determining their lineage propensity toward a specific destination. 9 However, the majority of these markers are known from in vitro propagation studies and they do not actually reflect the properties of DPSCs and SHED in vivo under physiologic condition or reparative process. Taking advantage of mouse incisor, which continuously grows throughout lifetime to compensate the lost tip during the occlusion, distinct marker expression of tooth pulp stem cells is disclosed. It is well known that most MSCs express CD90 in vitro, as aforementioned. However, as revealed by An et al, CD90 + cells account for 30% of incisor MSCs which contribute to 30% of pulp cells and odontoblasts during early postnatal development. 14 
Once
incisor growth homeostasis has been established after eruption in adult, CD90 + MSCs decrease substantially by twofold as compared to postnatal incisor, and the population of CD90 + MSCs which give rise to differentiation is approximately depleted and becomes nearly undetectable. The orthotopic studies of tooth pulp stem cells in mouse incisor also make great contribution to the discovery of new cell markers or subpopulations of tooth pulp stem cells. As per the lineage tracing in mouse incisor from Feng et al, in response to both postnatal growth and injury repair, NG2 + cells are capable of differentiating into polarized odontoblasts. 15 Especially 4 days following injury, more NG2 + odontoblasts are detected and extend stubby processes into newly synthesized reparative dentin. This indicates that NG2, commonly identified as a pericyte marker, represents an additional marker of incisor pulp MSCs in mouse. Recently, Gli1 has also been recognized orthotopically as a mouse incisor MSC marker, and Gli1 + cells support both the homeostasis and injury repair of mouse incisor. 16 Notably, the majority of Gli1 + cells in mouse incisor do not express classic in vitro markers of MSCs, including CD44, CD73, CD105, CD146, and nestin, indicating that classic MSC markers may not be efficient to confirm MSCs in vivo. Moreover, Celsr1, a marker known from hematopoietic stem cells, is identified to label a rare and quiescent subpopulation of MSCs in mouse incisor pulp. 14 
| Therapeutic applications
Depending on their multipotency and sensitivity to local paracrine activity, DPSCs and SHED exert therapeutic applications at multiple levels beyond the scope of the stomatognathic system, including locally intraoral pulp-dentin complex regeneration and systematically extraoral tissue repair and regeneration. However, the majority of aforementioned applications are conducted in animals, extensive (pre) clinical trials from bench to bedside are thus warranted.
| Pulp-dentin complex regeneration
The most apparent and promising application of DPSCs and SHED is pulp-dentin complex regeneration. Vital pulp, serving as the formative and supportive organ for dentin, is critical for tooth longevity. However, root canal treatment (RCT), as nonregenerative treatment, does not salvage dental pulp and tooth vitality but substitutes pulp tissue for inorganic materials, culminating with a devital and weakened tooth, which is susceptible to tooth fracture or even tooth loss. The emergence of regenerative endodontics brings brighter future and is recognized as a prospective approach for tooth preservation.
According to Murray et al, regenerative endodontics is referred to as biologically based procedures which are designed to replace damaged structures, including dentin and root structures, as well as cells of the pulp-dentin complex. 58 The ultimate purpose of regenerative endodontics is thus to regenerate viable pulp-dentin complex which histologically resembles the native tissue with anticipated physiological functions, including pulp innervation, pulp immunity, vascular perfusion, and tubular dentin formation. Revascularization treatment via blood clotting in root canal, which, although generates ectopic bone and cementum as well as fibrous tissue, shows the absence of histologic pulp-dentin structure, has been refuted as genuine tissue regeneration. In recent years, considerable research efforts have been used to advance the process of regenerative endodontics by virtue of cell transplantation and cell homing, extending our understanding of regenerative endodontics and promoting regenerative endodontics to more concise therapeutic approaches.
Cell transplantation-based regenerative endodontics
Cell transplantation is considered as transplantation of exogenous PSCs loaded into biocompatible scaffolds incorporated with biological signaling molecules into root canals. For regenerative endodontics, cell transplantation strategy is firstly proposed and extraordinary advances have been achieved.
Accompanied by the paramount discovery of DPSCs in human third molars and their outstanding capabilities to regenerate an ectopic pulp-dentin complex with odontoblasts lining against the dentin-like tissue, pulp-dentin complex regeneration via PSC transplantation has been a longstanding pursuit. Substantial attempts have been devoted to motivating the translation of PSC transplantationinduced pulp-dentin regeneration from laboratory to clinic, during which transplant models have evolved successively from ectopic dentin layer (perpendicular section), tooth slice (horizontal section, 1 mm thick), and root segment (horizontal section, 6-7 mm long) to orthotopic entire length of root canal. DPSCs cotransplanted with dentin layer, as a prelude, initiates regenerative endodontics. 59 It is illustrated to be capable of forming reparative dentin-like tissue on the pre-existing dentin layer. Organized dentinal tubules are absent in newly formed dentin; however, DPSCs first show potential to repair tooth structure and seal root canals. As a precursor, the triad of DPSCs, dentin matrix protein 1 (DMP-1), and collagen scaffold transplanted in tooth slice induces collagen matrix formation and enriched angiogenesis in pulp chamber. 60 However, newly formed hard tissue is not observed, and thus, the differentiation of odonto- pulp-like tissue and continuously deposited dentin with uniform thickness on root canal dentinal walls and MTA ( Figure 2 ). In spite of disorganized odontoblast-like cell layer and dentinal tubules, as well as embedment of odontoblast-like cell in dentin-like tissue, this work presents an immense step toward orthotopic pulp-dentin regeneration in alveolar bone.
Notably, the above experiments are conducted ectopically in immunocompromised mice. Furthermore, PSC transplantations are also processed orthotopically in large animals. Complete or partial pulp regeneration with additional dentin-like tissue deposition on canal walls has been achieved in dog noninfected pulpectomized [63] [64] [65] [66] [67] [68] and pulpotomized 69, 70 teeth, irrespective of total or fractionated dog PSCs and/or specifically used growth factors. An innovative orthotopic model is established in dog pulpectomized tooth canal, 63 in which the upper is transplanted with stromal-derived factor-1 (SDF-1), while the lower with dog CD105 + PSCs. As observed, it is more efficacious in pulp-dentin regeneration when compared with those achieved by either alone. The chemotaxis induction between homing factor SDF-1 and C-X-C chemokine receptor type 4 expressed on CD105 + PSCs accounts for the underlying mechanism. CD105 + stem cells migrate upward, proliferate, and release angiogenic factors and neurogenic factors, facilitating angiogenesis and neurogenesis as well as pulp regeneration. Minipigs, which share similar tooth and root canal morphology as well as overall head size with human, have also been used to present impressive results. 19 Exploiting the first minipig model, Zhu et al reported that pulpectomized root canals are replete with vascularized pulp tissue and accumulated osteodentin against the canal dentin following transplantation with autologous pig PSCs encapsulated in hyaluronic acid or collagen hydrogel. 71 These in situ experiments that are administrated in healthy and sound root canals, however, do not actually resemble the actual clinical teeth with infected or necrotic root canals. Verma et al transplanted allogeneic ferret PSCs into endodontically treated necrotic immature teeth which were subjected to apical periodontitis and illustrated that the residual bacteria significantly lead to lack of radiographic root growth and less dentin-like tissue formation. 72 Preclinical models, which better mimic an infected environment on microbial control, provide more predictable and translational results in future clinical trials. In a recent clinical trial, 19 autologous canine SHED aggregates implanted into necrotic immature permanent incisors of pediatric patients give rise to functional dental pulp regeneration with vasculature and innervation, as well as lining odontoblast layer. Moreover, the elongated root and closed apical foramen is evidenced, suggesting that the regenerated pulp tissue promotes tooth development ( Figure 3 ). Regarding the quality of regenerated dentin, probably due to accessibility issue, it is not illustrated. However, the safety is confirmed with a 24-month follow-up examination, as indicated by the absence of complications such as transplantation rejection and inflammation. Accordingly, PSC transplantation is indicative of immense scientific meritoriousness in clinical settings.
Notably, the availability of pulp tissue as a major obstacle hinders the feasibility and prevalence of autologous transplantation approach.
Except for wisdom teeth or orthodontic teeth, it is not realistic and clinically ethical to extract respective sound teeth for DPSCs. Specifically, in elderly patients, age-related pulp tissue shrinkage due to physiological secondary dentin generation and pathological tertiary dentin generation, as well as mineralization, including denticle and pulpal stones constrains the acquirement of DPSCs. In addition to reduction in quantity, their mobilization, differentiation, and regeneration capacities are adversely disturbed. 73, 74 Furthermore, for patients with systemic diseases such as diabetes, systemic lupus erythematosus, and rheumatoid arthritis, intrinsic properties of MSCs are irreversibly altered. 75 As an alternative, allogeneic transplantation seems to be a desirable approach to circumvent those problems. In particular, SHED possess higher proliferation rate and increased population doublings as compared with DPSCs, 18 . D, native dentin; DPSCs, dental pulp stem cells; MTA, mineral trioxide aggregate; Od, differentiated odontoblast-like cells; PLG, poly-D, L-lactide and glycolide; rD, regenerated dentin-like tissue; rP, regenerated pulp-like tissue reconstruction is brilliant. In the same year, cell homing for pulpdentin regeneration is initially proposed. 78 Irrespective of PSC isolation, expansion, and translation which cumulatively impede the efficiency of cell delivery approach, endogenous cells would be recruited directly to instrumented root canals under the instruction of bioactive molecules, followed by differentiation into pulp-dentin like tissues.
Apparently, cell homing potentiates the feasibility and efficiency of regenerative endodontics and acts as a complementary or alternative approach for cell transplantation. Accordingly, pulpotomy, commonly applied in deciduous teeth with the intent of preserving vital pulp, can also be conducted in immature and mature permanent teeth. In doing this, the resident PSCs, DPSCs, or SHED enable exert their intrinsic capabilities of initiating pulpdentin regeneration under the instruction of growth factors (Figure 4 ).
It should be addressed that cell sources dedicated to cell homing for pulp-dentin regeneration could also derive from periapical
MSCs. In cases of advanced pulpitis or necrosis, pulp is then F I G U R E 3 SHED regenerate pulp-dentin complex after implantation into children's traumatized permanent incisor teeth. Adapted from Reference 19 with permission. A, B, SHED-induced pulp-dentin complex regeneration in immunocompromised mice. A, SHED aggregates were inserted into empty human root canals and implanted subcutaneously for 8 weeks. H&E and Masson staining revealed remarkable pulp tissue regeneration, respectively. Enlarged regions are indicative of odontoblasts (black arrows) present at the margin of the regenerated pulp tissue and blood vessels (open arrows) observed in the regenerated pulp tissue. In the control group, calcium hydroxide mediated calcified tissue formation, instead of pulp tissue. B, Immunostaining showed dentin sialoprotein-positive odontoblasts (open black arrows) and calcein-positive newly formed dentin (white arrows) in the empty root canal of a human tooth. C, F, SHED-induced pulp-dentin complex regeneration in the incisor teeth of pediatric patients. C, D, Radiological examination showed that the length of the root (red lines in [C] and white stippled circles in [D]) was increased and the apical foramen (blue lines in [C]) was closed after SHED implantation. Additionally, the amount of dentin (white arrows in [D]) was increased. In the control group, positive indications were not presented after apexification treatment. E, Quantification disclosed that SHED implantation significantly increased vascular formation, sensation, root length, apical foramen width, and dentin thickness. F, Representative H&E image of a human incisor 12 months after SHED implantation showed regenerated pulp tissue with a similar tissue structure to that of normal human pulp tissue. Odontoblasts (black arrows) localized at the margin of the regenerated pulp tissue were observed. SHED, stem cells from human exfoliated deciduous teeth extirpated completely. It is plausible that locally populated MSCs from periapical region, including PDLSCs, SCAP, and alveolar BMSCs account for recruitment. 79, 80 In addition, systematically circulated stem/progenitor cells appear clinically available. 75 However, regarding the regenerated pulp-dentin anatomically mimicking native tissue, periapical stem cells appear less therapeutically applicable and feasible as compared with PSCs. Consensus holds that MSCs are distinctive and conserve their identities from their direct tissue sources and therefore tend to differentiate into original phonotypes. 76 The aforementioned revascularization treatment, which generates ectopic bone and cementum as well as fibrous tissue instead of histologic pulpdentin structure, seems indicative of this, especially considering evoked bleeding delivers periapical stem cells into root canal. Accordingly, rather than reparative tissue, the desired regeneration of pulpdentin complex which resembles the native tissue seems more likely to necessitate the presence of PSCs. The remnant viable pulp tissue after pulpotomy is determinant for cell homing-induced regenerative endodontics. Accordingly, more reliable approaches are warranted to distinguish irreversibly damaged pulp from healthy pulp for clinicians.
Optimized treatment protocol combining pulpotomy with cell homing strategy intimately is a prerequisite to enhance the chance of success.
Cell homing encompasses three distinct cellular processes, including cell recruitment, proliferation, and differentiation, which rely on the bioactivity of various growth factors delivered exogenously or endogenously. The growth factor delivery approaches define distinct procedures for cell homing-induced pulp-dentin regeneration. Accordingly, we will discuss the underlying rational and scientific basis in the following part, respectively.
Exogenous recombinant growth factors. A variety of exogenous growth
factors have been determined in vitro on their potentials in enhancing PSC migration, proliferation, and differentiation. Regarding induced migration, SDF-1, 79,81,82 basic fibroblast growth factor (bFGF), 81, 83 stem cell factor (SCF), 84, 85 and granulocyte-colony stimulating factor (GCSF) 83 exhibit superior potentials. Considering the proliferation, SCF, 84,85 bFGF 83 and GCSF, 83 as well as Wnt3a 86 are capable of promoting cell proliferation. Given the differentiation, BMP-7, 81 BMP-2, 83 and GCSF 83 represent significant advantages on dentinogenesis. It is noteworthy that, in addition to promoting migration, proliferation, and dentinogenesis, GCSF also stimulates angiogenesis and neurogenesis. 83 Thus, the versatile capabilities imply that GCSF might be a superior choice for cell homing-induced pulp-dentin regeneration.
Applying the first ectopic tooth model, Kim et al previously explored combinatory delivery effect of bFGF, vascular endothelial growth factor (VEGF), or platelet-derived growth factor with basal set of BMP-7 and nerve growth factor on cell homing-induced pulp-dentin regeneration in human real-sized endodontically treated teeth. 78 Apparent cellularization and vascularization is identified in entire canal space, indicative of pulp-like tissue formation. Additionally, new mineral deposition on native dentin is evidenced histologically for VEGF set and substantially enhanced dentin sialoprotein level is detected for both bFGF and VEGF combination groups. Although combined delivery of several growth factors is less clinically feasible and more economically expensive, this ectopic study supports the idea that pulp-dentin regeneration initiated by cell homing is available and stands as a step forward and scale up from cell delivery approach. Afterward, simplified approaches are conducted extensively to minimize delivery cumbersomeness and cost of regenerative endodontics. Diverse single delivery strategies, including bFGF, 81,83 GCSF, 83 SDF-1, 82 and SCF, 84, 85 have been demonstrated ectopically in tooth segments.
Orthotopically, Hunter et al revealed that upon acute pulp exposure in rat, Wnt3a preserves the pulp vitality and enhanced odontoblast differentiation, culminating in a highly organized tubular dentin relative to atubular osteodentin for control. 86 In future, sufficient F I G U R E 4 Schematics of cell homing-induced pulp-dentin regeneration. After pulpotomy, infected and inflamed pulp tissue is extirpated, while healthy pulp tissue is preserved, and endogenous PSCs are accordingly available. Depending on exogenously added or endogenously liberated growth factors from dentin matrix, remaining PSCs in root canals in recruited, followed by pulp-dentin regeneration in the absence of cell transplantation. PSC, pulp stem cell
Endogenous dentin matrix-derived growth factors: Prospect of cell homing. During dentin development, odontoblasts secrete a multitude of bioactive growth factors, which are subsequently immobilized by hydroxyapatite crystals to form mineralized dentin. Solubilization of these growth factors may occur through several therapeutic dental materials, such as MTA, calcium hydroxide, and self-etching adhesives.
Hence, liberating growth factors from dentin matrix allows a sustained endogenous supply to induce pulp-dentin regeneration and circum- is the most commonly used chelating agent regarding its ability to dissolve smear layer and soften dentin. In addition, EDTA is capable of liberating growth factors sequestered in dentin matrix. It was depicted that 10% EDTA (pH 7) for 20 minutes gives rise to the highest amount of TGF-β1 (923 pg/mL), as compared with 10%
EDTA (pH 6) and 17% EDTA (pH 7) (449 pg/mL and 827 pg/mL, respectively). 87 The release of bFGF and VEGF is also revealed under 10% EDTA (pH 7), however, less effective relative to TGF-β1 (bFGF, 10 pg/mL, VEGF, 32 pg/mL after 20-minute exposure). As summarized in Table 2 , an abundance of growth factors has been shown to be present in EDTA-soluble fraction of human demineralized dentin matrix. From the perspective of regenerative endodontics, upon releasing from dentin matrix by EDTA conditioning, growth factors are to be reactivated and initiate regenerative capability. As demonstrated in vitro, 10% EDTA (pH 7) for 10 minutes significantly promotes DPSC migration toward conditioned dentin discs. 100 Also, EDTA conditioning preserves DPSC viability and allows for their attachment with cytoplasmic processes extending onto dentin surface and into dentinal tubes, as well as results in up to threefold higher expression of mineralization-associated marker genes. Worth noting, 20-or 10-minute treatment is not acceptable in clinical settings. The difficulty in balancing the benefit of EDTA on growth factor release and clinically friendly application time raises the question of whether applying EDTA within a scaffold to support the regenerating pulp-dentin complex on a permanent basis is the optimal protocol. In this regard, compelling in vivo evidences are presented by tooth slices combined with PLA scaffolds which are pretreated with 10% EDTA (pH 7.2) for 1 minute in advance. 101 It was revealed that DPSCs seeded in tooth slice/PLA but not in control PLA express odontoblastic markers such as DMP-1, dentin sialophosphoprotein (DSPP), and matrix extracellular phosphoglycoprotein in vitro and ectopically regenerate pulp-like tissue with morphological characteristics resembling native dental pulp. Likewise, these findings are confirmed by SHED which are capable of regenerating vascularized pulp tissue and tubular dentin. 44, 93 Further research is warranted to determine the (pre)clinical efficacy. Pang Note: Adapted from Reference 99 with permission. Abbreviations: BDNF, brain-derived neurotrophic factor; bFGF, basic fibroblast growth factor; BMP-2, bone morphogenetic protein 2; EGF, epidermal growth factor; GDF-15, growth/differentiation factor 15; GDNF, glial cell line-derived neurotrophic factor; HGF, hepatocyte growth factor; IGF-1, insulin growth factor-1; PDGF, platelet-derived growth factor; PIGF, placenta growth factor; TGF-β1, transforming growth factor beta 1; VEGF, vascular endothelial growth factor. compared with cells cultured on untreated dentin or without direct contact with EDTA-treated dentin. 102 It is indicated that the trinity combination of recruited PSCs and liberated growth factors with EDTA-solubilized dentin surface which possesses specific topography and mechanical properties is a prerequisite for odontoblast differentiation during a (pre)clinical procedures of regenerative endodontics. In other words, in (pre)clinical root canals, EDTA conditioning establishes concentration gradients of growth factors and consequently chemoattracts PSC migration into upper canal and toward solubilized dentin surface. For those PSCs located in root canal without contact with dentin surface, angiogenesis and neurogenesis are anticipated and pulp regeneration is accordingly achieved. Contrastingly, as regards PSCs attached on solubilized dentin surface, they predominately devote to odontoblastic differentiation and dentin regeneration. It is presumed that in a pre(clinical) protocol, EDTA treatment as a final endodontic irrigant has a desirable prospect for cell-homing induced pulp-dentin regeneration. 100 If EDTA conditioning is to be advocated as the final step of an irrigation protocol for regenerative endodontics in clinical situation, it is paramountly crucial to confirm that root canal disinfectants do not impede the release of growth factors. Due to excellent bactericidal efficacy, sodium hypochlorite solutions (NaOCl) and chlorhexidine (CHX) are commonly applied to collaborate with EDTA in clinic as intracanal irrigants. However, irrigation with 5.25% NaOCl, a clinically advocated concentration, prior to 10% EDTA (pH 7) conditioning considerably reduces TGFβ-1 release from dentin disks, while CHX before EDTA conditioning increases TGF-β1 release. 87 Considering disinfectants will render a direct contact with residual healthy PSCs, it is imperative to create a conducive microenvironment in root canal which will benefit PSC behaviors, including migration, attachment, proliferation, and differentiation. Unfortunately, 5.25% NaOCl not only inhibits DPSC migration toward dentin disks but also prevents their attachment and differentiation on dentin surface. 100 It is not surprising in terms of deproteinization and cytotoxicity effect of NaOCl.
When SHED encapsulated in tooth slice/PLA are transplanted subcutaneously, 93 NaOCl conditioning gives rise to disorganized tissue in pulp cavity and inhibits odontoblastic differentiation, indicative of the deleterious effect that NaOCl imposes on remaining PSCs. As a matter of fact, previous clinical study has revealed that 5% and 0.5% NaOCl do not result in significantly different antibacterial efficacies. 103 Consistently, a latest clinical investigation reports a nonremarkable difference in periapical healing as well as postoperative pain incidence between 5% NaOCl and 1% NaOCl. 104 Based on these results, it can be deduced that there is no tremendous advantage of into newly regenerated tubular dentin should be considered together.
The third case in point is that regenerating tubular dentin remains fairly challenging. Organized dentinal tubules in newly formed dentin are less predictable. This is presumably associated with insufficient signals for differentiation and maturation of odontoblast-like cells and diminished number of odontoblast-like cells. Accordingly, it is beneficial and significant to provide optimal signals for odontoblastic differentiation of recruited cells. To that end, copine 7, a preameloblast-derived factor which enhances generation of organized dentinal tubules in root segment model, seems to be a promising candidate. 106 Last but not least, from a functional regeneration standpoint, the efficacy of pulp-dentin complex regeneration in animal tooth models is predominantly validated by using histological approaches, while in the absence of functional neural and vascular testing. Combination with functional innervation and vascularization appears more persuasive for functional pulp regeneration. 107 118 Additionally, predifferentiated PSCs, including hepatocytes, 125 myocytes, 128 osteoblasts, 143 islet-like cell cluster, 45 and keratocytes, 137 Table 3 , such as calvarial defect, 110 cerebral ischemia, 116, 117 and limbal stem cell deficiency, 38 It was also reported that SHED are capable of differentiating into hepatocyte-like cells directly without fusion in mouse models of carbon tetrachloride-induced liver fibrosis, therefore recovering liver disfunction. 41 In a recent mouse in vivo study, 12 
| Extraoral tissue repair and regeneration

108
Acute renal injury SHED Cryopreserved SHED were transferred intravenously or intraperitoneally into glycerol-induced acute renal failure rats. SHED homed to kidney and accelerated renal tubule epithelial cell regeneration.
109
Nephritis SHED SHED were transferred intravenously into systemic lupus erythematosus MRL/lpr mice.
Hypercellularity, mesangial matrix hyperplasia, and basal membrane disorder were prevented histologically, while serum creatinine, urine protein, and C3 were significantly reduced, serum albumin was elevated. SHED-CM attenuated pro-inflammatory response, and induced anti-inflammatory M2-like microglia, substantially improving cognitive function.
112
Cerebral ischemia SHED SHED-CM was injected intranasally into middle cerebral artery occlusion-induced ischemia rats. SHED-CM promoted neurogenesis and angiogenesis, ameliorating ischemic brain injury.
113
Cerebral ischemia SHED SHDE and SHED-CM were transplanted into hypoxia-ischemia-injured neonatal mice. Both SHED and SHED-CM remarkably suppressed brain loss, while augmented survival rate and neurological function.
114
Traumatic brain injury SHED SHED or SHED-Ex were injected into external mechanical force-injured rat brains.
SHED-Ex significantly ameliorated behavioral score and lesion recovery, while suppressed pro-inflammatory M1microglia.
115
Cerebral ischemia DPSCs DPSCs were injected intracerebrally into middle cerebral artery occlusion-induced ischemia rats. Forelimb sensorimotor function was significantly ameliorated.
116
Cerebral ischemia DPSCs DPSCs and BMSCs were transplanted intravenously into middle cerebral artery occlusion-induced ischemia rats, respectively.
DPSCs were superior to BMSCs in terms of reducing infarct volume and reactive gliosis as well as promoting angiogenesis.
117
Parkinson's disease SHED dSHED or SHED were transplanted into striatum of 6-hyroxydopamine-induced Parkinsonian rats. dSHED were more efficient to improve dopamine level and promoted neurological recovery in contrast to SHED. The transplantation significantly suppressed liver fibrosis and restored alanine transaminase, aspartate transaminase, and ammonia levels.
125
Heart Ischemia-reperfusion injury SHED SHED-CM was intravenously injected in left anterior descending artery ligation-induced ischemia-reperfusion injury mice.
SHED-CM reduced myocardial infarct size as well as decreased apoptosis and inflammatory cytokine levels.
126
Acute myocardial infarction
DPSCs DPSCs were injected intramyocardially in coronary artery ligation-induced myocardial infarction rats. Cardiac function was improved with thickened anterior wall of left ventricle, reduced infarct size, and increased angiogenesis.
127
Muscle Muscular dystrophy SHED SHED were transplanted singly or consecutively into golden retriever muscular dystrophy dogs via intra-arterial or intramuscular injection. SHED were capable of engrafting, differentiating, and persisting in the affected muscle in the absence of immunosuppression. Intra-arterial and consecutive delivery was more effective.
29
Muscular dystrophy
DPSCs DPSCs were transplanted intramuscularly into muscular dystrophy mice DPSCs engrafted and integrated in muscular fibers, as well as enhanced angiogenesis.
12
Muscular dystrophy DPSCs Predifferentiated DPSCs were injected into gastrocnemius muscles of mdx/SCID mice.
Recovery effect was observed through paracrine-mediated angiogenesis and fibrosis reduction.
128
Bone Calvarial defect SHED SHED-Cryo or SHED-Fresh were transplanted into calvarial bone defect in mice.
Similar with SHED-Fresh, SHED-Cryo differentiated into bone-forming cells and formed bone-like structure and bone marrow-like component, contributing to calvarial defect regeneration.
110
Calvarial defect SHED SHED primed with bFGF or hypoxia were transplanted into mouse calvarial defects.
The primings enhanced arrangement of collagenous extracellular matrix and mineral formation, especially under bFGF priming.
129
Osteoporotic disorder SHED SHED-Cryo or SHED-Fresh were transplanted intravenously into osteoporotic disorder MRL/lpr mice.
Both SHED-Cryo and SHED-Fresh significantly ameliorated osteoporotic disorder of tibiae, increasing trabecular parameters, and reducing TRAP + cells.
110
ONFH SHED SHED were transplanted into ethanol-induced ONFH sheep. DPSCs stimulated revascularization and re-epithelialization, ameliorating collagen deposition, and organization in healing wounds.
12
Pancreas Diabetes SHED Islet like-cell clusters derived from SHED were packed in macrocapsules and then transplanted subcutaneously into streptozotocin-induced diabetic mice. Mice were restored to normoglycemia within 3-4 wk and retained normoglycemia for 2 mo., while their body weight and glucose level in urine reverted to normal levels.
45
Diabetes SHED SHED-CM was injected into streptozotocin-induced diabetic mice.
SHED-CM markedly suppressed plasma glucose and retained this effect for 20 d, which was related to enhanced pancreatic β-cell proliferation and insulin secretion.
135
Diabetic neuropathy
DPSCs DPSCs were transplanted into streptozotocin-induced neuropathic rats via intravenous or intramuscular route in single or two repeated doses.
Both routes and doses were beneficial for the retrieval of neuropathic parameters, and intramuscular route with repeat dose was superior.
136
Eye Limbal stem cell deficiency SHED SHED sheet was transplanted onto corneal bed of NaOH-induced limbal stem cell deficiency rabbit.
SHED reconstructed corneal, improving its transparency.
38
Cornea trauma
DPSCs
Keratocyte differentiated DPSCs were injected into mouse corneal stroma.
Corneal stromal extracellular matrix containing human type I collagen and keratocan was formed, while corneal transparency was not affected and immunological rejection was not induced.
137
Glaucoma DPSCs DPSCs were transplanted intravitreally into TGF-β-induced glaucoma rats. The number of retinal ganglion cells and the thickness of retinal nerve fiber layer were protected. 
141
Note: Adapted from Reference 142 with permission. Abbreviations: bFGF, basic fibroblast growth factor; BMSCs, bone marrow-derived mesenchymal stem cells; DPSCs, dental pulp stem cells; DPSCs-HGF, DPSCs transduced with hepatocyte growth factor gene; dSHED, differentiated SHED; hFibro, human fibroblasts; hMSCs, human mesenchymal stromal cells; iSHED, neural-induced SHED; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; ONFH, osteonecrosis of femoral head; PSCs, pulp stem cells; SHED, stem cells from human exfoliated deciduous teeth; SHED-CM, SHED conditioned medium; SHED-Cryo, SHED derived from cryopreserved pulp tissue; SHED-Ex, SHED-derived exosomes; SHED-Fresh, SHED isolated from fresh pulp tissue; TGF-β, transforming growth factor beta.
considered that both neural differentiation and paracrine mechanism are responsible for SHED-induced therapeutic potential for contused spinal cord injury. Likewise, it has been demonstrated that SHED transplantation ameliorate liver fibrotic disfunction via integrated actions of both direct hepatocyte differentiation 41 and indirect paracrine mechanism-mediated antifibrosis and anti-inflammation potentials. 124 Consequently, in terms of mechanisms underlying PSC transplantation-derived benefits, it is important to note that paracrine mechanism initiated by therapeutic factors secreted from transplanted PSCs, at least partially, participates in treatment and enhances endogenous tissue repair capability.
The attachment and survival of transplanted PSCs at the lesion site is determinant on the following multipotential differentiation.
Once PSCs fail to survive in the injury sites, their direct contribution to tissue recovery will be diminished or even abolished, which, however, is not implicated in their indirect paracrine-dependent efficacy on tissue recovery in some instances. As revealed by SHED transplantation for acute lung injury treatment, 111 a progressive reduction of surviving SHED occurs in lung, from 10% over a 2 to 24 hours time period after transplantation to less than 1% 1 week after transplantation. However, SHED promote such significant recovery as SHED-CM thereafter to the end of the study, ascertaining that powerful paracrine mechanism elicited by SHED mediates durable therapeutic potential. In another instance, irrespective of scarce homing and distribution in bone, SHED intravenous transplantation pronouncedly reduces ovariectomy-induced bone loss in the trabecular bone of the distal femur metaphysis. 132 In contrast, it is extraordinarily noteworthy that survived cells do not imply they are definitely capable of differentiating and compensating for the lost cells. 138 In a study which revealed remarkable therapeutic effects of both SHED and SHED-CM on the recovery of neonatal hypoxia-ischemia brain injury, 114 rheumatoid arthritis, 139 and spinal cord injury. 122 Treatment of autoimmune encephalomyelitis mice with recombinant ED-Siglec-9 recapitulates therapeutic efficacy of SHED-CM treatment, indicating that ED-Siglec-9 is a paramount factor mediating SHED-CM potential for encephalomyelitis treatment. 140 Hepatocyte growth factor, originally known as mitogen for hepatocytes, is more highly expressed in SHED-CM compared with BMSC-CM. 126 It is reported to play a pivotal role in SHED-CM-mediated inhibitory actions on myocardial infarct size and apoptosis following ischemia-reperfusion.
In addition to soluble factors, exosomes derived from SHED-CM (SHED-Ex) are reportedly attributable to the functional recovery of diabetes, 135 traumatic brain injury, 115 propagation on bench, cell survival concern at lesion site, and such potential safety hazards as tumorigenesis compared with cell transplantation.
| Cell banking
Due to easy accessibility and favorable therapeutic applications of PSCs, cell banking has attracted additional attention. Clinically acquired teeth and harvested whole pulp tissues as well as isolated DPSCs and SHED can be cryopreserved to maintain their stemness capacity for many years, providing a banked stem cell source for further use. Furthermore, with the induction of GCSF, mobilized dental pulp stem cells (MDPSCs) are isolated from DPSCs. 145 Extraordinarily, MDPSCs from aged human donors are as potent as those from young donors, revealing no obvious distinction in terms of migration, multipotent differentiation as well as pulp-like tissue regeneration in ectopic tooth. Hence, these cells might be proper candidates for PSC banking, irrespective of the MSC aging-associated decrease in regenerative potential. Recently, cell/tissue banks in the dental field have been taken into practice in several countries, such as BioEDEN (Austin, Texas) and Store-A-Tooth (Lexington, Kentucky).
| CONCLUSION
Following the innovative discovery of DPSCs almost 20 years ago, PSCs have been paving the way for the substantial advancement of tissue engineering and regenerative medicine, ranging from endodontic regeneration to extensive extraoral applications. Tremendous efforts have been made to simplify PSCs-dependent endodontic regeneration procedures, from the absence of cell transplantation to dependence on endogenous growth factors in an attempt to facilitate clinical practice.
Orthotopic pulp-dentin regeneration has been realized through SHED transplantation, however, whether DPSC transplantation or solo growth factor induction possess the similar capability is still elusive.
Alternatively, recruiting periapical MSCs is highly appreciated if epigenetic regulation of odontogenic capability of PDLSCs, SCAP, or BMSCs is achieved to regenerate pulp-dentin complex in a true sense. Identification of epigenetic factors warrants further investigation, such as Wnt3a. 146 Actually, dental MSC inspired-endodontic regeneration approach seems more conservative in comparison with total tooth organ regeneration strategy, which holds the highest promise for dis- 
